1. Home
  2. EVN vs IVA Comparison

EVN vs IVA Comparison

Compare EVN & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVN
  • IVA
  • Stock Information
  • Founded
  • EVN 1998
  • IVA 2011
  • Country
  • EVN United States
  • IVA France
  • Employees
  • EVN N/A
  • IVA N/A
  • Industry
  • EVN Investment Bankers/Brokers/Service
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVN Finance
  • IVA Health Care
  • Exchange
  • EVN Nasdaq
  • IVA Nasdaq
  • Market Cap
  • EVN 410.0M
  • IVA 359.6M
  • IPO Year
  • EVN N/A
  • IVA 2020
  • Fundamental
  • Price
  • EVN $10.42
  • IVA $3.22
  • Analyst Decision
  • EVN
  • IVA Strong Buy
  • Analyst Count
  • EVN 0
  • IVA 4
  • Target Price
  • EVN N/A
  • IVA $10.50
  • AVG Volume (30 Days)
  • EVN 101.2K
  • IVA 16.4K
  • Earning Date
  • EVN 01-01-0001
  • IVA 09-24-2025
  • Dividend Yield
  • EVN 4.78%
  • IVA N/A
  • EPS Growth
  • EVN N/A
  • IVA N/A
  • EPS
  • EVN 0.34
  • IVA N/A
  • Revenue
  • EVN N/A
  • IVA $14,591,573.00
  • Revenue This Year
  • EVN N/A
  • IVA $15.38
  • Revenue Next Year
  • EVN N/A
  • IVA $24.22
  • P/E Ratio
  • EVN $29.94
  • IVA N/A
  • Revenue Growth
  • EVN N/A
  • IVA N/A
  • 52 Week Low
  • EVN $8.64
  • IVA $1.53
  • 52 Week High
  • EVN $10.45
  • IVA $4.05
  • Technical
  • Relative Strength Index (RSI)
  • EVN 52.84
  • IVA 48.15
  • Support Level
  • EVN $10.33
  • IVA $2.85
  • Resistance Level
  • EVN $10.75
  • IVA $3.41
  • Average True Range (ATR)
  • EVN 0.12
  • IVA 0.25
  • MACD
  • EVN 0.01
  • IVA -0.01
  • Stochastic Oscillator
  • EVN 38.04
  • IVA 48.41

About EVN Eaton Vance Municipal Income Trust

Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: